Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

CEO and President Shaff Eric D. converted options into 27,837 shares and sold $6,037 worth of shares (8,748 units at $0.69), increasing direct ownership by 13% to 165,082 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MCRB· Seres Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.